Arctic Therapeutics Enrolls First Patients in Phase IIa Trial of AT-004 for Acne Vulgaris
Arctic Therapeutics (ATx) has enrolled the first patients in its Phase IIa randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of topical AT-004 for treating acne...

